Drug major Cipla on Thursday announced the appointment of Samina Vaziralli as executive director on its board, paving way for a bigger role for her, nearly two weeks after another heir apparent Kamil Hamied quiting the pharma company.
Winds of change is blowing at the country's oldest and the second largest drug firm Cipla. With the current chairman and managing director Y K Hamied deciding to retire from his post of the managing director on March 31 and continuing as non executive chairman.
Dr.YK Hamied, CMD, Cipla will retire with effect on March 31.Talking to CNBC-TV18 about his retirement plans, YK Hamied, CMD, Cipla says, “We now have built up a very strong senior management team and time has come to let the youngsters‘ takeover.